Filip Borgions
Chief Tech/Sci/R&D Officer bei ARGENX SE
Profil
Filip Borgions is currently the Global Head-Technical Operations at argenx SE since 2015.
Previously, he worked as a Principal at Thrombogenics, Inc. Dr. Borgions has an undergraduate and doctorate degree from Katholieke Universiteit Leuven.
Aktive Positionen von Filip Borgions
| Unternehmen | Position | Beginn |
|---|---|---|
| ARGENX SE | Chief Tech/Sci/R&D Officer | 01.01.2015 |
Ehemalige bekannte Positionen von Filip Borgions
| Unternehmen | Position | Ende |
|---|---|---|
Thrombogenics, Inc.
 Thrombogenics, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Oxurion NV, Thrombogenics, Inc. operates as a biotechnology company that delivers innovative treatments for diseases of the back of the eye, with a focus on diabetic eye disease. The private company is based in New York, NY. | Corporate Officer/Principal | - |
Ausbildung von Filip Borgions
| Katholieke Universiteit Leuven | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| ARGENX SE | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Thrombogenics, Inc.
Thrombogenics, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Oxurion NV, Thrombogenics, Inc. operates as a biotechnology company that delivers innovative treatments for diseases of the back of the eye, with a focus on diabetic eye disease. The private company is based in New York, NY. | Commercial Services |
